Ontology highlight
ABSTRACT: Background
Accrual to cancer clinical trials is suboptimal. Few data exist regarding whether financial reimbursement might increase accruals.Objective
The objective of this study was to assess perceptions about reimbursement to overcome barriers to trial accrual.Research design
This was a cross-sectional survey.Subjects
Oncologists identified from the American Medical Association Physician Masterfile.Measures
We report descriptive statistics, associations of physician characteristics with perceptions of reimbursement, domains, and subthemes of free-text comments.Results
Respondents (n=1030) were mostly medical oncologists (59.4%), ages 35-54 (67%), and male (75%). Overall, 30% reported discussing trials with >25% of patients. Barriers perceived were administrative/regulatory, physician/staff time, and eligibility criteria. National Cancer Institute cooperative group participants and practice owners were more likely to endorse higher reimbursement. Respondents indicated targeted reimbursement would help improve infrastructure, but also noted potential ethical problems with reimbursement for discussion (40.7%) and accrual (85.9%). Free-text comments addressed reimbursement sources, recipients, and concerns about the real and apparent conflict of interest.Conclusions
Though concerns about a potential conflict of interest remain paramount and must be addressed in any new system of reimbursement, oncologists believe reimbursement to enhance infrastructure could help overcome barriers to trial accrual.
SUBMITTER: Lee SJC
PROVIDER: S-EPMC8026490 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature
Lee Simon J Craddock SJC Murphy Caitlin C CC Gerber David E DE Geiger Ann M AM Halm Ethan E Nair Rasmi G RG Cox John V JV Tiro Jasmin A JA Skinner Celette S CS
Medical care 20210501 5
<h4>Background</h4>Accrual to cancer clinical trials is suboptimal. Few data exist regarding whether financial reimbursement might increase accruals.<h4>Objective</h4>The objective of this study was to assess perceptions about reimbursement to overcome barriers to trial accrual.<h4>Research design</h4>This was a cross-sectional survey.<h4>Subjects</h4>Oncologists identified from the American Medical Association Physician Masterfile.<h4>Measures</h4>We report descriptive statistics, associations ...[more]